Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination.
about
Human malarial disease: a consequence of inflammatory cytokine releasePfHRP2 measures schizogony, not mechanical blockageComplementation of essential yeast GPI mannosyltransferase mutations suggests a novel specificity for certain Trypanosoma and Plasmodium PigB proteinsDetermination of the processes driving the acquisition of immunity to malaria using a mathematical transmission modelPlasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.Interaction between Plasmodium Glycosylphosphatidylinositol and the Host Protein Moesin Has No Implication in Malaria Pathology.Parasite Carbohydrate Vaccines.Neutralization of malaria glycosylphosphatidylinositol in vitro by serum IgG from malaria-exposed individuals.Exposure-dependent control of malaria-induced inflammation in children.Malaria tolerance--for whom the cell tolls?Signaling Strategies of Malaria Parasite for Its Survival, Proliferation, and Infection during Erythrocytic Stage.IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.Naturally elicited antibodies to glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum require intact GPI structures for binding and are directed primarily against the conserved glycan moiety.
P2860
Q21034098-5FED9F59-4FF6-4A08-AEC8-C4C043CAAAF9Q25256482-863DD56F-B1C9-4205-98E9-4AFAA7922E7BQ30041017-81282A65-9D83-4D76-8B68-416FF15C9F2CQ33312850-D13E09DD-CFCD-4A9E-A63F-E4DFD337CA84Q33556308-84A01828-83F7-40D8-A158-ADA89DAB34D2Q33689702-4678DD9A-295C-4090-99F0-76CC33E36796Q33785863-CE471859-B494-4829-B54D-CEF731ADA164Q34119412-29BB79EC-C6EB-4E22-9323-1C6529C5BDFFQ35152209-DE5D80A6-B7F4-4925-95AB-EDF0F72ADECBQ36511461-CE620984-F9D2-4D39-B682-BB7A26B8D7A6Q39236108-1DDEDD49-41A1-4B08-8C57-3B9649F205F2Q41956908-C03EBB6D-B1F0-48F2-9C5B-B824D66374F2Q42135656-D495B4F4-1CEA-4705-B6D4-0BAE492118B2
P2860
Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Glycosylphosphatidylinositols ...... ic inhibition and vaccination.
@ast
Glycosylphosphatidylinositols ...... ic inhibition and vaccination.
@en
type
label
Glycosylphosphatidylinositols ...... ic inhibition and vaccination.
@ast
Glycosylphosphatidylinositols ...... ic inhibition and vaccination.
@en
prefLabel
Glycosylphosphatidylinositols ...... ic inhibition and vaccination.
@ast
Glycosylphosphatidylinositols ...... ic inhibition and vaccination.
@en
P2093
P1476
Glycosylphosphatidylinositols ...... ic inhibition and vaccination.
@en
P2093
C S Boutlis
J B de Souza
N M Anstey
P304
P577
2005-01-01T00:00:00Z